Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

The Trump administration announced its newest pharmaceutical agreement under its Most Favored Nation policy Thursday, ...

President Trump's plan drops the price of Ozempic and Wegovy for Americans, with plans for Medicare to cover the popular ...

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

The deals are among the most politically significant announcements to date in the Trump administration's efforts to rein in ...

The Trump administration initially walked back a Biden-era attempt to broaden Medicare coverage of weight loss drugs, which ...

The Trump administration is expected to announce deals with Eli Lilly and Novo Nordisk to cut prices of some weight loss ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

The agreement will make Wegovy and Zepbound available to some Medicare enrollees for $245 per month, and starter doses of ...

Trump administration negotiating with Novo Nordisk and Eli Lilly to lower Wegovy, Zepbound prices to $149/month, with some ...

US President Donald Trump has announced deals that aim to lower the cost of popular weight loss drugs, as phramaceutical prices take centre stage in his administration's messaging around affordability ...

President Trump will announce concessions from Eli Lilly and Novo Nordisk that would lower the price of some of the companies ...